Tumor recurrence and metastasis often occur in HCC patients after surgery, and the prognosis is not optimistic. Hence, searching effective biomarkers for prognosis of is of great importance. Firstly, HCC-related data was acquired from the TCGA and GEO databases. Based on GEO data, 256 differentially expressed genes (DEGs) were obtained firstly. Subsequently, to clarify function of DEGs, clusterProfiler package was used to conduct functional enrichment analyses on DEGs. Protein-protein interaction (PPI) network analysis screened 20 key genes. The key genes were filtered via GEPIA database, by which 11 hub genes (F9, CYP3A4, ASPM, AURKA, CDC20, CDCA5, NCAP, PRC1, PTTG1, TOP2A, and KIFC1) were screened out. Then, univariate Cox analysis was ap...
BACKGROUND: Hepatocellular carcinoma (HCC) is the most common type of liver tumour, and is closely r...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Hepatocellular carcinoma (HCC) is a common malignant cancer with poor survival outcomes, and hepatit...
Hepatocellular carcinoma (HCC) is a common malignancy. However, the molecular mechanisms of the prog...
Objective The objective was to identify potential hub genes associated with the pathogenesis and pro...
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and has poor outcomes. Howe...
Hepatocellular carcinoma (HCC) is an aggressive cancer type with poor prognosis; thus, there is espe...
BackgroundHepatitis C virus-induced genes (HCVIGs) play a critical role in regulating tumor developm...
Hepatocellular carcinoma is a common malignant tumor with poor prognosis, poor treatment effect, and...
Hepatocellular carcinoma (HCC) is one of the major cancer-related deaths worldwide. Genomic instabil...
The aim of the current study was to identify biomarkers that correlate with the Barcelona Clinic Liv...
The aim of the current study was to identify biomarkers that correlate with the Barcelona Clinic Liv...
The aim of the current study was to identify biomarkers that correlate with the Barcelona Clinic Liv...
Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors with the poor prognosis...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
BACKGROUND: Hepatocellular carcinoma (HCC) is the most common type of liver tumour, and is closely r...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Hepatocellular carcinoma (HCC) is a common malignant cancer with poor survival outcomes, and hepatit...
Hepatocellular carcinoma (HCC) is a common malignancy. However, the molecular mechanisms of the prog...
Objective The objective was to identify potential hub genes associated with the pathogenesis and pro...
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and has poor outcomes. Howe...
Hepatocellular carcinoma (HCC) is an aggressive cancer type with poor prognosis; thus, there is espe...
BackgroundHepatitis C virus-induced genes (HCVIGs) play a critical role in regulating tumor developm...
Hepatocellular carcinoma is a common malignant tumor with poor prognosis, poor treatment effect, and...
Hepatocellular carcinoma (HCC) is one of the major cancer-related deaths worldwide. Genomic instabil...
The aim of the current study was to identify biomarkers that correlate with the Barcelona Clinic Liv...
The aim of the current study was to identify biomarkers that correlate with the Barcelona Clinic Liv...
The aim of the current study was to identify biomarkers that correlate with the Barcelona Clinic Liv...
Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors with the poor prognosis...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
BACKGROUND: Hepatocellular carcinoma (HCC) is the most common type of liver tumour, and is closely r...
Aim: Existing targeted therapies for hepatocellular carcinoma (HCC) are resistant and have limitatio...
Hepatocellular carcinoma (HCC) is a common malignant cancer with poor survival outcomes, and hepatit...